Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 6/2013

01-06-2013 | Letter to the Editor

Prognostic factors of primary gastric diffuse large B cell lymphoma: a retrospective study of 75 cases in China

Authors: Yong-xin Wu, Bo Liu, Li Chen, Jun-he Li, Shao-qing Chen

Published in: Annals of Hematology | Issue 6/2013

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Jezersek NB, Vovk M, Juznic ST (2006) A single-center study of treatments outcomes and survival in patients with primary gastric lymphoma between 1990 and 2003. Ann Hematol 85(12):849–856CrossRef
2.
Medina-Franco H, Germes SS, Maldonado CL (2007) Prognostic factors in primary gastric lymphoma. Ann Surg Oncol 14(8):2239–2245PubMedCrossRef
3.
Ho CL, Hsieh AT, Dai MS et al (2005) Non-Hodgkin’s lymphoma of the stomach: treatment outcomes for 57 patients over a 20-year period. J Chin Med Assoc 68(1):11–15PubMedCrossRef
4.
Parvez T, Behani A, Ali A (2007) Primary gastric lymphoma. J Coll Physicians Surg Pak 17(1):36–40PubMed
5.
Ibrahim EM, Ezzat AA, Raja MA, Ajarim DS, Mann B et al (1999) Primary gastric non-Hodgkin’s lymphoma: clinical features, management, and prognosis of 185 patients with diffuse large B-cell lymphoma. Ann Oncol 10:1441–1449PubMedCrossRef
6.
Zhang J, Hu X, Liu X, Wu X, Sun S, Zhang Q et al (2010) Prognostic factors in primary gastric non-Hodgkin’s lymphoma—a single center retrospective analysis of 103 cases from China. Hepatogastroenterology 57(101):989–996PubMed
7.
Binn M, Ruskoné-Fourmestraux A, Lepage E, Haioun C, Delmer A et al (2003) Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma. Ann Oncol 14(12):1751–1757PubMedCrossRef
8.
Kim SJ, Cheong JW, Hahn JS (2007) Therapeutic comparison of chemotherapy and surgery for early stage diffuse large B-cell gastric lymphoma. Yonsei Med J 48(6):942–948PubMedCrossRef
9.
Avilé A, Nambo MJ, Neri N, Huerta-Guzmán J et al (2004) The role of surgery in primary gastric lymphoma: results of a controlled clinical trial. Ann Surg 240(1):44–50CrossRef
10.
Wöhrer S, Püspök A, Drah J, Hejna M, Chott A, Raderer M et al (2004) Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) for treatment of early-stage gastric diffuse large B-cell lymphoma. Ann Oncol 15(7):1086–1090PubMedCrossRef
Metadata
Title
Prognostic factors of primary gastric diffuse large B cell lymphoma: a retrospective study of 75 cases in China
Authors
Yong-xin Wu
Bo Liu
Li Chen
Jun-he Li
Shao-qing Chen
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 6/2013
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-012-1646-4

Other articles of this Issue 6/2013

Annals of Hematology 6/2013 Go to the issue

Letter to the Editor

Haemophilia A associated with Down’s syndrome

Original Article

A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components

Original Article

Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial

Original Article

Prevalence and incidence of anemia in the German Heinz Nixdorf Recall Study

Letter to the Editor

Autoimmune hemolytic anemia with warm-reactive immunoglobulin M antibody in multicentric Castleman disease

Original Article

Clinical evaluation of the European LeukemiaNet response criteria in patients with essential thrombocythemia treated with anagrelide
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits